Group One Trading
APGE

Group One Trading’s Apogee Therapeutics APGE Stock Holding History

Group One Trading’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133K Sell
1,000
-19,000
-95% -$1.71M ﹤0.01% 4614
2026
Q1 		$1.68M Buy
20,000
+18,800
+1,567% +$1.37M ﹤0.01% 2223
2025
Q4 		$90.6K Sell
1,200
-4,200
-78% -$265K ﹤0.01% 5079
2025
Q3 		$215K Buy
+5,400
New +$206K ﹤0.01% 4604
2025
Q2 		– Sell
-3,400
Closed -$127K – 7901
2025
Q1 		$127K Buy
3,400
+1,900
+127% +$73.5K ﹤0.01% 4419
2024
Q4 		$68K Buy
+1,500
New +$76.5K ﹤0.01% 4825

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Group One Trading's APGE Position: Q2 2026 in Review

Group One Trading reduced its Apogee Therapeutics (APGE) stake by 70% in Q2 2026, selling an estimated $50.7K and leaving 237 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5700.

Group One Trading first reported a position in APGE in Q2 2024 and has held it in 8 quarters since. The position peaked at $79.8K in Q4 2025. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Group One Trading held 237 shares of Apogee Therapeutics worth $31.5K as of Q2 2026.
  • Group One Trading sold 563 Apogee Therapeutics shares in Q2 2026, an estimated $50.7K.
  • Apogee Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5700 holding.
  • Group One Trading first reported a position in Apogee Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Group One Trading's Apogee Therapeutics position peaked at $79.8K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.